seekingalpha.com
/1 week ago
Latest updates for Dprrx
Fresh curated links around DPRRX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript
- Nomura Global Listed Real Assets Fund Q1 2026 Commentary
- GoodRx Holdings, Inc. (GDRX) Q1 2026 Earnings Call Transcript
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
seekingalpha.com
/3 weeks ago
GoodRx Holdings, Inc. (GDRX) Q1 2026 Earnings Call Transcript
seekingalpha.com
/1 month ago
Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside
seekingalpha.com
/4 weeks ago
Pacira BioSciences, Inc. 2026 Q1 - Results - Earnings Call Presentation
finance.yahoo.com
/2 weeks ago
Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib
seekingalpha.com
/2 weeks ago
Royalty Pharma: Strong Execution, Expanding Pipeline And More Firepower Ahead
fool.com
/3 days ago
PDSB Q4 2025 Earnings Call Transcript
Image source: The Motley Fool. DATEWednesday, May 13, 2026 at 8 a.m. ETCALL PARTICIPANTSChief Executive Officer — Frank Bedu-AddoChief Medical Officer — Kirk ShepardChief Financia...
seekingalpha.com
/2 weeks ago
Ars Pharmaceuticals anticipates CVS Caremark decision as it expands $199 retail access program
seekingalpha.com
/1 month ago
LB Pharmaceuticals Inc (LBRX) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
pharmexec.com
/1 week ago
<![CDATA[TrumpRx Expands to Offer Generic Medications]]>
seekingalpha.com
/1 month ago
Definium Therapeutics, Inc. (DFTX) Analyst/Investor Day - Slideshow
fool.com
/2 weeks ago
OptimizeRx (OPRX) Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATETuesday, May 12, 2026, at 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Stephen L. SilvestroChief Financial Officer — Edward StelmakhCh...
seekingalpha.com
/1 week ago
GoodRx: TrumpRx Exposes Legacy Moat Breach And Zero-Sum Strategy (Downgrade)
pharmexec.com
/1 month ago
<![CDATA[FDA Issues CRL to Replimune for RP1 Biologics License Application for Advanced Melanoma Treatment ]]>
seekingalpha.com
/1 month ago
Rexford Industrial Realty, Inc. (REXR) Q1 2026 Earnings Call Transcript
seekingalpha.com
/1 month ago
Astellas Pharma Inc. (ALPMY) Discusses R&D Strategy and Focus Areas in Innovative Healthcare - Slideshow
fool.com
/2 weeks ago
PDSB Q1 2026 Earnings Transcript
Image source: The Motley Fool. DATEWednesday, May 13, 2026 at 8 a.m. ETCALL PARTICIPANTSChief Executive Officer — Frank Bedu-AddoChief Medical Officer — Kirk ShepardChief Financia...
seekingalpha.com
/1 month ago
Deutsche EuroShop AG (DHRPY) Q4 2025 Earnings Call Transcript
pharmexec.com
/1 week ago
<![CDATA[Pharmaceutical Executive Daily: FDA Approves Datroway]]>
drugs.com
/4 weeks ago
FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug Daraxonrasib
May 01, 2026 -- Today, the U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an ex...
pharmexec.com
/1 month ago
<![CDATA[Pharmaceutical Executive Daily: FDA Issues Second CRL for Replimune's RP1 Melanoma Treatment]]>
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Dprrx
seekingalpha.com
Recent coverage from public sources
Public source
finance.yahoo.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
drugs.com
Recent coverage from public sources
Public source
fool.com
Recent coverage from public sources
Public source